Hemoglobin Testing, Red Blood Cell Count, and Hematocrit: Application Differences
Hemoglobin Testing, Red Blood Cell Count, and Hematocrit: Application Differences
Hemoglobin testing, red blood cell count, and hematocrit are three of the most fundamental indicators in red blood cell system evaluation. All three are related to anemia, erythrocytosis, blood loss, dehydration, and hematopoietic function, but their detection targets are different: hemoglobin reflects the amount of oxygen-carrying protein in blood, red blood cell count reflects the number of erythrocytes per unit volume, and hematocrit reflects the volume fraction of red blood cells in whole blood. In clinical and research analysis, these three indicators should be interpreted together, and none of them should be used to completely replace the others.
Keywords: hemoglobin; red blood cell count; hematocrit; HGB; RBC; HCT; anemia; red blood cell indices; MCV; MCH; MCHC; whole blood testing; erythropoiesis; hemolysis; glycated hemoglobin
1 Basic Logic of Red Blood Cell System Testing
1.1 Detection Targets of the Three Indicators
(1) Hemoglobin testing
Hemoglobin testing mainly measures the mass concentration of hemoglobin in whole blood, commonly expressed in g/L or g/dL. Hemoglobin is the core protein responsible for oxygen binding and oxygen transport in red blood cells. Therefore, HGB is usually a key indicator for determining the severity of anemia and the oxygen-carrying capacity of blood.
(2) Red blood cell count
Red blood cell count measures the number of red blood cells per unit volume of whole blood, commonly expressed as ×10¹²/L. RBC reflects the number of red blood cells, but it does not directly reflect the amount of hemoglobin in each red blood cell, nor does it independently reflect red blood cell size.
(3) Hematocrit
Hematocrit refers to the proportion of red blood cell volume in whole blood volume, commonly expressed as L/L or as a percentage. HCT is affected by both red blood cell count and mean red blood cell volume, and is also significantly influenced by changes in plasma volume.
1.2 Relationship Among the Three Indicators
Hemoglobin, red blood cell count, and hematocrit together form the basis of red blood cell system analysis. HGB primarily reflects oxygen-carrying capacity, RBC primarily reflects red blood cell number, and HCT primarily reflects the total red blood cell volume fraction. When interpreted together, they can be used to further calculate or derive mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration.
Table 1 Core Differences Among Hemoglobin, Red Blood Cell Count, and Hematocrit
Indicator | English Abbreviation | Main Detection Target | Result Meaning | Main Application |
Hemoglobin | HGB/Hb | Hemoglobin concentration in whole blood | Reflects the amount of oxygen-carrying protein in blood | Assessment of anemia severity, blood loss evaluation, erythrocytosis evaluation |
Red blood cell count | RBC | Number of red blood cells per unit volume | Reflects changes in red blood cell number | Erythropoietic status and auxiliary classification of anemia |
Hematocrit | HCT/PCV | Proportion of red blood cell volume in whole blood | Reflects total red blood cell volume fraction | Evaluation of dehydration, anemia, erythrocytosis, and hemoconcentration |
2 Hemoglobin Testing
2.1 Detection Significance
(1) Evaluation of oxygen-carrying capacity
Hemoglobin is the core determinant of blood oxygen transport capacity. Decreased HGB usually suggests anemia or hemodilution, while increased HGB may be seen in erythrocytosis, chronic hypoxia, dehydration, or hemoconcentration.
(2) Determination of anemia severity
The diagnosis and grading of anemia usually rely more on hemoglobin concentration than on red blood cell count alone. Even when red blood cell count is normal or elevated, hypochromic anemia may still occur if the hemoglobin content of individual red blood cells is insufficient.
(3) Monitoring of treatment and intervention
After treatment with iron, folic acid, vitamin B12, erythropoietin, blood transfusion, or therapy for hematologic diseases, changes in HGB can be used to evaluate overall treatment response. However, reticulocytes, iron metabolism, and red blood cell indices should also be considered to determine the recovery mechanism.
2.2 Common Detection Methods
(1) Cyanmethemoglobin method
The cyanmethemoglobin method is a classic hemoglobin assay. It converts various forms of hemoglobin into stable derivatives for colorimetric measurement. This method has good accuracy, but cyanide-containing reagents are toxic and require specific waste disposal procedures. Therefore, it has been replaced by cyanide-free methods in some laboratories.
(2) SDS-Hb/SLS-Hb methods
SDS-Hb or SLS-Hb methods use surfactants to lyse red blood cells and form stable hemoglobin complexes, making them suitable for colorimetric methods and automated detection systems. Their advantage is avoiding cyanide use, which makes them suitable for routine samples and batch testing.
(3) Methemoglobin oxidation method
The methemoglobin oxidation method converts hemoglobin into a specific oxidation state for colorimetric measurement. It can be used for hemoglobin content analysis in whole blood, hemolysates, or experimental model samples.
(4) Immunoassay detection
ELISA and other immunoassays are suitable for detecting hemoglobin of specific species, free hemoglobin, glycated hemoglobin, or abnormal hemoglobin-related indicators. Their advantage is stronger specificity, but they are generally not used to replace basic HGB testing in routine hematology analyzers.
2.3 Result Interpretation
Decreased HGB may be seen in iron deficiency anemia, anemia of chronic disease, aplastic anemia, hemolysis, acute or chronic blood loss, nutritional deficiency, and hemodilution. Increased HGB may be seen in polycythemia vera, chronic hypoxia, high-altitude adaptation, dehydration, and hemoconcentration. HGB alone cannot distinguish the cause of anemia and must be interpreted together with MCV, MCH, MCHC, reticulocytes, and iron metabolism indicators.
Table 2 Comparison of Main Hemoglobin Detection Methods
Method | Basic Principle | Advantages | Limitations | Applicable Scenarios |
Cyanmethemoglobin method | Hemoglobin is converted into a stable derivative for colorimetric measurement | Classic, stable, good comparability | Cyanide-containing reagent; high waste disposal requirements | Standardized colorimetric testing and methodological control |
SDS-Hb/SLS-Hb method | Surfactant lyses red blood cells and forms a stable complex | Cyanide-free, suitable for routine colorimetric or automated systems | Depends on reagent and instrument systems | Hb content detection and automated hematology analysis |
Methemoglobin oxidation method | Hemoglobin is oxidized to generate a detectable signal | Can be used for colorimetric and micro assays | Oxidation reaction conditions must be controlled | Whole blood, hemolysate, and animal experiment samples |
ELISA method | Specific antigen-antibody recognition | Strong species or indicator specificity | Higher cost; not suitable for replacing routine CBC HGB | Detection of Hb, f-Hb, GHb, HbA1c, and related indicators |
3 Red Blood Cell Count
3.1 Detection Significance
(1) Evaluation of red blood cell number
RBC reflects the number of red blood cells in whole blood per unit volume and is an important indicator for evaluating erythropoiesis, red blood cell destruction, and hemoconcentration. Increased RBC does not necessarily indicate enhanced oxygen-carrying capacity, and decreased RBC does not always match the degree of HGB reduction.
(2) Auxiliary classification of anemia
RBC has important auxiliary value in anemia classification. For example, iron deficiency anemia is often accompanied by decreased HGB and decreased or low-normal RBC; thalassemia carrier status may show relatively high RBC with markedly reduced MCV. If only HGB is evaluated, the discrepancy between red blood cell number and volume may be overlooked.
(3) Analysis of erythropoietic status
When combined with reticulocytes, red cell distribution width, and bone marrow erythroid response, RBC can help determine insufficient erythropoiesis, recovery after blood loss, compensatory response after hemolysis, and hematopoietic stimulation status.
3.2 Common Detection Methods
(1) Manual counting method
Traditional red blood cell counting can be performed by diluting whole blood with red blood cell diluent and counting under a microscope using a hemocytometer. This method requires relatively simple equipment, but it has large operational errors and is significantly affected by dilution ratio, counting area, cell distribution, and manual reading.
(2) Electrical impedance method
The electrical impedance method counts and analyzes cell volume based on changes in electrical resistance when cells pass through a detection aperture. It is one of the common principles used in automated hematology analyzers. This method is suitable for high-throughput testing, but it may be affected by cell aggregation, debris, platelet abnormalities, or cold agglutination.
(3) Light scattering and flow analysis
Some hematology analyzers use laser scattering, fluorescent staining, or flow channels to analyze red blood cells and other blood cells. These methods improve cell classification and abnormal cell recognition, but results still need to be interpreted together with instrument flags and smear review.
3.3 Result Interpretation
Decreased RBC may be seen in anemia, blood loss, hemolysis, insufficient bone marrow hematopoiesis, and hemodilution. Increased RBC may be seen in erythrocytosis, chronic hypoxia, dehydration, high-altitude exposure, and increased erythropoietin associated with certain tumors. RBC must be interpreted together with HGB and HCT, because RBC count may not be low in microcytic anemia, while RBC reduction may be more obvious in macrocytic anemia.
Table 3 Comparison of Red Blood Cell Count Methods
Method | Technical Features | Advantages | Limitations | Applicable Scenarios |
Hemocytometer method | Microscopic counting after dilution | Low equipment requirement; useful for teaching and review | Large manual error and poor repeatability | Manual experiments and when instruments are unavailable |
Electrical impedance method | Counts cells based on electrical signals when cells pass through an aperture | Fast, automated, good repeatability | Susceptible to agglutination, debris, and abnormal particles | Routine hematology analysis |
Light scattering method | Analyzes cell characteristics based on scattering signals | Provides more cellular information | Depends on instrument algorithms | Advanced hematology analyzers |
Flow/fluorescence method | Identifies cells using staining or optical signals | Stronger abnormal sample recognition | Higher cost and instrument requirements | Special samples and abnormal flag review |
4 Hematocrit
4.1 Detection Significance
(1) Total red blood cell volume fraction
HCT indicates the proportion of total red blood cell volume in whole blood volume. It is affected by both red blood cell count and mean red blood cell volume, so it can reflect changes in hemoconcentration, hemodilution, and red blood cell mass.
(2) Assessment of hemoconcentration and dehydration
In dehydration, burns, plasma loss, or hemoconcentration, HCT may increase. HGB and RBC may also increase simultaneously, but the main cause may be reduced plasma volume rather than an absolute increase in red blood cell production.
(3) Evaluation of infusion, blood loss, and shock
In early acute blood loss, HGB and HCT may not immediately decrease. After fluid infusion, hemodilution can reduce HCT. Therefore, HCT interpretation should consider the time course, fluid therapy, hemodynamics, and clinical context.
(1) Microhematocrit method
After capillary centrifugation, the ratio of packed red blood cells to total blood column length is read. This method is intuitive and can be used for manual testing and teaching, but it is affected by centrifugation conditions, residual plasma, buffy coat, reading error, and red blood cell morphology.
(2) Automated hematology analyzer calculation method
Most automated hematology analyzers do not directly measure HCT by centrifugation, but calculate it based on RBC and MCV: HCT ≈ RBC × MCV. This method is fast and stable, but when RBC count or MCV is affected by interference, HCT will also deviate.
(3) Point-of-care estimation systems
Some point-of-care or blood gas systems provide estimated HCT values, which are suitable for dynamic monitoring in emergency departments, ICUs, and perioperative settings. However, these values may differ methodologically from standard hematology analyzer or centrifugation results.
4.3 Result Interpretation
Decreased HCT may be seen in anemia, hemodilution, fluid infusion after blood loss, and reduced erythropoiesis. Increased HCT may be seen in dehydration, erythrocytosis, chronic hypoxia, and reduced plasma volume. Since HCT is strongly affected by plasma volume, it cannot be used alone to determine whether red blood cell production is increased.
Table 4 Comparison of Hematocrit Detection Methods
Method | Basic Principle | Advantages | Limitations | Applicable Scenarios |
Microcentrifugation method | Reads packed red blood cell proportion after centrifugation | Intuitive and relatively simple equipment | Affected by centrifugation and reading | Manual testing, teaching, on-site review |
Automated calculation method | HCT is calculated from RBC and MCV | Fast and suitable for batch samples | Depends on the accuracy of RBC and MCV | Routine hematology analysis |
Point-of-care estimation | Estimated through conductivity or related models | Fast and suitable for bedside testing | May differ from standard HCT | Emergency, ICU, bedside monitoring |
5 Differences Among the Three Indicators in Anemia Analysis
5.1 HGB Is Used to Determine Anemia Severity
Anemia is usually primarily determined by decreased HGB. The lower the HGB, the more obvious the reduction in blood oxygen-carrying capacity. Clinical grading and treatment decisions usually focus more on HGB than on RBC or HCT alone.
5.2 RBC Helps Identify Mismatch Between Number and Volume
RBC helps identify number-volume mismatches in microcytic and macrocytic anemia. For example, thalassemia carrier status may present with relatively high RBC, decreased MCV, and mildly decreased HGB; iron deficiency anemia is more commonly associated with decreased or low-normal RBC, decreased MCV, and increased RDW.
5.3 HCT Reflects Red Blood Cell Mass and Plasma Volume Effects
HCT is affected by both red blood cell mass and plasma volume. Increased HCT during dehydration may reflect hemoconcentration; decreased HCT after large-volume infusion may reflect hemodilution. In anemia analysis, HCT helps evaluate changes in total red blood cell volume, but it should not be interpreted apart from HGB.
Table 5 Change Patterns of the Three Indicators in Common Conditions
Condition | HGB | RBC | HCT | Interpretation Points |
Iron deficiency anemia | Decreased | Decreased or low-normal | Decreased | Often accompanied by decreased MCV and MCH and increased RDW |
Thalassemia carrier status | Mildly decreased or near normal | Normal or increased | Normal or mildly decreased | RBC-MCV mismatch is an important clue |
Macrocytic anemia | Decreased | Decreased | Decreased | Increased MCV and obvious reduction in RBC number |
Early acute blood loss | May be temporarily near normal | May be temporarily near normal | May be temporarily near normal | Dynamic recheck is needed; decreases become more obvious after fluid infusion |
Dehydration/hemoconcentration | Increased | May increase | Increased | Mainly affected by reduced plasma volume |
Polycythemia vera | Increased | Increased | Increased | Should be combined with EPO, JAK2, and bone marrow examination |
Hemodilution during pregnancy | Decreased or mildly decreased | Variable | Decreased | Dilution effect caused by increased plasma volume |
6 Combined Application of Red Blood Cell Indices
6.1 Mean Corpuscular Volume
MCV reflects the average volume of a single red blood cell and is commonly used for morphological classification of anemia. Decreased MCV suggests microcytic anemia, commonly seen in iron deficiency, thalassemia, and anemia related to chronic inflammation. Increased MCV suggests macrocytic anemia, commonly seen in folate or vitamin B12 deficiency, liver disease, alcohol-related changes, and myelodysplasia.
6.2 Mean Corpuscular Hemoglobin
MCH reflects the average amount of hemoglobin contained in a single red blood cell and is affected by both HGB and RBC. MCH is often decreased in microcytic hypochromic anemia.
6.3 Mean Corpuscular Hemoglobin Concentration
MCHC reflects the hemoglobin concentration inside red blood cells and is affected by both HGB and HCT. Decreased MCHC is commonly seen in hypochromic anemia. Abnormally increased MCHC should raise suspicion for spherocytes, cold agglutination, severe hemolysis, or instrument interference.
Table 6 Relationship Between Red Blood Cell Indices and the Three Basic Indicators
Red Blood Cell Index | Calculation Logic | Dependent Indicators | Main Significance |
MCV | HCT/RBC | HCT, RBC | Reflects average single red blood cell volume |
MCH | HGB/RBC | HGB, RBC | Reflects average hemoglobin amount per red blood cell |
MCHC | HGB/HCT | HGB, HCT | Reflects average hemoglobin concentration in red blood cells |
RDW | Variation in red blood cell volume distribution | Red blood cell volume distribution | Reflects anisocytosis |
7 Common Interfering Factors
7.1 Sample Coagulation or Insufficient Mixing
If whole blood samples contain microclots, RBC count and HCT may be falsely low, and HGB measurement may also be affected. After blood collection, samples should be thoroughly mixed with EDTA anticoagulant to avoid clotting and cell sedimentation.
7.2 Hemolysis
In vitro hemolysis releases hemoglobin and may affect HGB measurement and red blood cell count. Mild hemolysis has limited influence on some HGB methods, but it can reduce RBC count and cause mismatch between HGB and RBC.
7.3 Cold Agglutination
Cold agglutination causes red blood cells to aggregate. Automated instruments may identify multiple red blood cells in clumps as fewer large cells, leading to falsely low RBC, falsely high MCV, and abnormal HCT and MCHC. Repeating the test after warming the sample can help identify this interference.
7.4 Hyperlipidemia and Jaundice
Severe lipemia, jaundice, or hyperproteinemia can affect colorimetric HGB measurement by increasing absorbance background. In such cases, blank correction, plasma replacement, or instrument flag review should be performed according to laboratory procedures.
7.5 Extreme Leukocytosis
Extreme leukocytosis can affect the colorimetric background of HGB and red blood cell-related parameters, especially in leukemia samples. Smear review and instrument flag information should be considered.
Table 7 Common Interferences and Result Biases for the Three Indicators
Interfering Factor | HGB Effect | RBC Effect | HCT Effect | Handling Direction |
Sample clot | May be low or unstable | Low | Low | Recollect or reject the sample |
In vitro hemolysis | May be high or mismatched with RBC | Low | Low | Review according to hemolysis degree |
Cold agglutination | Variable | Falsely low | May be abnormal | Retest after incubation at 37°C |
Lipemia | Colorimetric method may be falsely high | Usually less affected | Indirectly affected | Blank correction or plasma replacement |
Extremely high leukocytes | May be affected by turbidity | Channel interference | May be abnormal | Smear review and instrument correction |
Insufficient mixing | Fluctuating results | Marked deviation | Marked deviation | Mix thoroughly and retest |
8 Application Scenarios
8.1 Routine Physical Examination and Anemia Screening
HGB, RBC, and HCT are the most basic red blood cell parameters in routine blood tests. In physical examination screening, decreased HGB usually suggests a risk of anemia; RBC and HCT can further help determine whether microcytic, macrocytic, hemodilution, or hemoconcentration tendencies are present.
8.2 Clinical Anemia Classification
Anemia classification cannot rely only on HGB. HGB is used to determine anemia severity, MCV and MCH are used for morphological classification, RBC is used to identify specific patterns such as thalassemia carrier status, and HCT helps evaluate red blood cell volume and dilution status.
8.3 Blood Loss and Infusion Monitoring
In acute blood loss, perioperative settings, and ICU patients, HGB and HCT are often used for transfusion decisions and blood volume assessment. However, results are affected by fluid infusion, timing of blood loss, and plasma volume. Dynamic changes are more valuable than a single result.
8.4 High Altitude, Hypoxia, and Erythrocytosis Research
In chronic hypoxia, high-altitude adaptation, lung disease, and polycythemia vera, HGB, RBC, and HCT often increase together. Increased HCT is closely related to increased blood viscosity and should be interpreted together with blood oxygen, EPO, JAK2, and clinical presentation.
8.5 Animal Experiments and Research Models
In animal models, HGB, RBC, and HCT are commonly used to evaluate anemia models, inflammatory anemia, hemolysis models, hypoxia models, drug toxicity, and hematopoietic intervention. Reference intervals differ significantly among species, and human reference ranges should not be directly applied.
Table 8 Priority Indicators in Different Application Scenarios
Application Scenario | Priority Indicators | Auxiliary Indicators | Interpretation Focus |
Anemia screening | HGB | RBC, HCT, MCV | Decreased HGB is the core signal |
Differentiation of microcytic anemia | MCV, MCH, RBC | HGB, RDW | Distinguish iron deficiency from thalassemia patterns |
Dehydration and hemoconcentration | HCT | HGB, RBC | Focus on plasma volume changes |
Acute blood loss | Dynamic changes in HGB and HCT | Reticulocytes, hemodynamics | A single result may lag behind |
Erythrocytosis | HGB, HCT, RBC | EPO, blood oxygen, JAK2 | Distinguish absolute from relative increase |
Animal anemia models | HGB, RBC, HCT | Reticulocytes, iron metabolism | Species-specific reference ranges are required |
9 Selection of Related Reagents and Detection Materials
Table 9 Product Selection for Hemoglobin Testing, Red Blood Cell Count, and Red Blood Cell-Related Experiments
Product Category | Cat. No. | Product Name | Grade / Specification | Role in the System | Applicable Direction |
Hemoglobin content detection | Hemoglobin Content Assay Kit (SDS-Hb, Micro Method) | BioReagent | Measures hemoglobin content in samples through the SDS-Hb system | Micro-sample Hb detection, animal experiments, whole blood or hemolysate analysis | |
Hemoglobin content detection | Hemoglobin Content Assay Kit (SDS-Hb, Colorimetric Method) | BioReagent | Measures hemoglobin content by colorimetric assay | Routine Hb quantification and batch sample testing | |
Hemoglobin content detection | Hemoglobin Content Assay Kit (Hematin, Micro Method) | BioReagent | Performs micro-detection based on color reaction after hemoglobin oxidation | Micro Hb quantification and methodological control | |
Hemoglobin content detection | Hemoglobin Content Assay Kit (Hematin, Colorimetric Method) | BioReagent | Performs Hb colorimetric measurement through the methemoglobin oxidation system | Hemoglobin content analysis and related detection in whole blood or tissue samples | |
Hemoglobin standard/material | Hemoglobin | From Bovine blood | Can be used as hemoglobin-related experimental material or methodological reference | Hb standard curves, method validation, hemoglobin structure and oxidation studies | |
Abnormal hemoglobin material | Hemoglobin S | ≥99% | Provides HbS-related research material | Sickle hemoglobin-related research and abnormal Hb method validation | |
Free hemoglobin detection | Free Hemoglobin (FHb) Content Assay Kit (o-Tolidine, Colorimetric Method) | BioReagent | Detects free hemoglobin in plasma, serum, or samples | Hemolysis evaluation, blood storage injury, red blood cell destruction studies | |
Free hemoglobin ELISA | Rat Free Haemoglobin (f-Hb) ELISA Kit | BioReagent | Detects free Hb levels in rat samples | Rat hemolysis models, intravascular hemolysis, red blood cell injury evaluation | |
Free hemoglobin ELISA | Mouse Free Haemoglobin (f-Hb) ELISA Kit | BioReagent | Detects free Hb levels in mouse samples | Mouse hemolysis models, red blood cell destruction, and hematotoxicity studies | |
Human Hb ELISA | Human Hemoglobin (Hb) ELISA Kit | BioReagent | Immunoassay-based quantification of human Hb | Human sample Hb detection and bleeding/hemolysis-related research | |
Rat Hb ELISA | Rat Hemoglobin (Hb) ELISA Kit | BioReagent | Immunoassay-based detection of rat Hb | Rat anemia models, hemolysis models, and animal experiment sample analysis | |
Mouse Hb ELISA | Mouse Hemoglobin (Hb) ELISA Kit | BioReagent | Immunoassay-based detection of mouse Hb | Mouse anemia, hematopoietic intervention, and hematotoxicity models | |
Glycated hemoglobin detection | Human Glycated Haemoglobin (GHb) ELISA Kit | BioReagent | Detects glycated hemoglobin in human samples | Glucose metabolism and diabetes-related red blood cell indicator research | |
Glycated hemoglobin detection | Rat Glycated Haemoglobin (GHb) ELISA Kit | BioReagent | Detects rat GHb | Rat diabetes models and long-term glucose exposure evaluation | |
Glycated hemoglobin detection | Rat Glycated Hemoglobin A1C (GHbA1c) ELISA Kit | BioReagent | Detects rat HbA1c levels | Rat diabetes models and glycation end-product-related research | |
Glycated hemoglobin detection | Mouse Glycated Hemoglobin (GHb) ELISA Kit | BioReagent | Detects mouse GHb | Mouse glucose metabolism models and diabetes-related research | |
Glycated hemoglobin detection | Mouse Glycated Hemoglobin A1c(GHbA1c) ELISA Kit | BioReagent | Detects mouse HbA1c levels | Mouse diabetes models and long-term glycemic control evaluation | |
Hemoglobin variant detection | Mouse Haemoglobin C (HbC) ELISA Kit | BioReagent | Detects mouse HbC-related indicators | Abnormal hemoglobin and red blood cell disease model research | |
Carboxyhemoglobin detection | Carbon monoxide hemoglobin detection kit (colorimetric method) | BioReagent | Detects COHb levels | Carbon monoxide exposure and hemoglobin binding status analysis | |
Methemoglobin functional detection | Methemoglobin Reduction Assay Kit (Colorimetric Method) | BioReagent | Evaluates methemoglobin reduction capacity | Methemoglobinemia, oxidative damage, and red blood cell reducing capacity research | |
Red blood cell counting solution | Red Blood Cell Dilution (Counting Solution) | BioReagent,Biological Stain,for microscopy | Dilutes whole blood and maintains red blood cell counting conditions | Manual red blood cell counting, hemocytometer method, teaching and review experiments | |
Red blood cell washing solution | Red Blood Cell Washing Solution (pH 7.2) | BioReagent,sterile | Washes red blood cells and removes plasma and soluble interfering substances | Red blood cell experimental pretreatment, hemolysis experiments, membrane function research | |
Red blood cell osmotic fragility detection | Erythrocyte Osmotic Fragility Assay Kit (Parpart, Colorimetric Method) | BioReagent | Evaluates red blood cell sensitivity to rupture in hypotonic environments | Red blood cell membrane stability, hereditary spherocytosis models, hemolysis research | |
Whole blood quality control / reference material | Certified Reference Materials for Blood Cell | analytical standard | Used as quality control and calibration reference for blood cell analysis methods | Quality control for hematology analyzers and RBC/HGB/HCT-related testing | |
Urine sediment RBC standard | Urine sediment red blood cell reference material | red blood cell:(400~ 600)/μL U≤ 10% | Provides reference for urine sediment red blood cell counting | Quality control of urine sediment RBC counting; not a core CBC RBC/HCT test | |
Red blood cell lysis buffer | ACK Red Blood Cell Lysis Buffer (ACK Lysis Buffer) | BioReagent | Lysing red blood cells to remove RBC interference | Leukocyte analysis and flow cytometry pretreatment; not used for RBC counting itself | |
Red blood cell lysis buffer | Gey's Red Blood Cell Lysis Buffer (Gey's Lysis Buffer) | BioReagent | Selectively lyses red blood cells | Immune cell isolation and leukocyte experiment pretreatment | |
Red blood cell lysis buffer | Tris-Ammonium Chloride Red Blood Cell Lysis Buffer (Sterile) | sterile-filtered,BioReagent,sterile | Ammonium chloride system for red blood cell lysis | Flow cytometry, cell culture pretreatment, immune cell analysis | |
Red blood cell lysis buffer | Red Blood Cell Lysis Buffer | BioReagent, sterile-filtered, for cell culture, 10x | Lysing red blood cells while preserving leukocyte components | Leukocyte isolation and sample pretreatment | |
Erythropoietin detection | Human Erythropoietin (EPO) ELISA Kit | BioReagent | Detects human EPO levels | Anemia mechanism, hypoxia response, and erythropoiesis regulation | |
Erythropoietin detection | Human Erythropoietin/EPO ELISA Kit | BioReagent | Detects human EPO | Hematopoietic regulation, renal anemia, and hypoxia models | |
EPO receptor detection | Human Erythropoietin Receptor (EPOR) ELISA Kit | BioReagent | Detects EPOR levels | EPO signaling pathway, erythroid differentiation, and hematopoietic regulation research | |
Erythropoietin detection | Rat Erythropoietin (EPO) ELISA Kit | BioReagent | Detects rat EPO | Rat anemia, hypoxia, and kidney injury models | |
Erythropoietin detection | Rat Erythropoietin/EPO ELISA Kit | BioReagent | Detects rat EPO | Erythropoiesis regulation research | |
Erythropoietin detection | Mouse Erythropoietin (EPO) ELISA Kit | BioReagent | Detects mouse EPO | Mouse anemia, hypoxia, and hematopoietic stimulation models | |
Erythropoietin detection | Mouse Erythropoietin/EPO ELISA Kit | BioReagent | Detects mouse EPO | Mouse erythropoiesis regulation research | |
Erythropoietin detection | Monkey Erythropoietin (EPO) ELISA Kit | BioReagent | Detects monkey EPO | Non-human primate anemia, hypoxia, and hematopoietic models | |
Red blood cell membrane protein detection | Human Erythrocyte Membrane Protein Band 4.2 (EPB42) ELISA Kit | BioReagent | Detects red blood cell membrane skeleton-related protein | Red blood cell membrane stability and hereditary hemolytic anemia-related research | |
Red blood cell complement receptor detection | Human Complement Receptor Type 1 (CR1) ELISA Kit | BioReagent | Detects red blood cell CR1 | Red blood cell immune adherence and complement-related research | |
Hemolysis-related serum | SRBC Ab | BioReagent, sterile, Potency 1:4000 | Reacts with sheep red blood cells for hemolysis systems | Complement hemolysis experiments and immune hemolysis models | |
Red blood cell agglutination-related | PHA-E (red kidney bean) | BioReagent, ≥80%, Erythroagglutinin PHA-E | Can induce red blood cell agglutination or be used in agglutination-related studies | Red blood cell agglutination and cell surface glycan-related experiments | |
Red blood cell agglutination-related | Phaseolus Vulgaris Erythroagglutinin |
| Red blood cell agglutination-related reagent | Red blood cell agglutination experiments and glycan recognition studies |
Hemoglobin, red blood cell count, and hematocrit describe the status of the red blood cell system from three dimensions: oxygen-carrying protein concentration, cell number, and red blood cell volume fraction. HGB is more suitable for assessing anemia severity, RBC is more suitable for analyzing red blood cell number and clues to anemia type, and HCT is more suitable for reflecting changes in red blood cell mass and plasma volume. Only when these indicators are interpreted together with MCV, MCH, MCHC, RDW, and clinical context can the nature and cause of red blood cell abnormalities be accurately determined.
